GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+14.11%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$374M
AUM Growth
+$374M
(+13%)
Cap. Flow
+$9.27M
Cap. Flow
% of AUM
2.48%
Top 10 Holdings %
Top 10 Hldgs %
34.22%
Holding
89
New
22
Increased
17
Reduced
12
Closed
26
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$13M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$9.84M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$9.53M |
| 4 |
ELGX
Endologix Inc
ELGX
|
$9.41M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$9.24M |
Top Sells
| 1 |
Abbott
ABT
|
$15.4M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$14.1M |
| 3 |
CELG
Celgene Corp
CELG
|
$12.7M |
| 4 |
SHPG
Shire pic
SHPG
|
$12.2M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$7.61M |
Sector Composition
| 1 | Healthcare | 86.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
77
Rocket Pharmaceuticals
RCKT
$358M
| – | – |
0
| – | – |
|
78
Perrigo
PRGO
$3.21B
| – | – |
-70,000
| Closed | -$5.83M |
|
79
iShares Russell 2000 ETF
IWM
$66.6B
| – | – |
0
| – | – |
|
80
iRhythm Technologies
IRTC
$5.67B
| – | – |
-115,182
| Closed | -$3.46M |
|
81
Glaukos
GKOS
$5.42B
| – | – |
-200,000
| Closed | -$6.86M |
|
82
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-100,000
| Closed | -$5.84M |
|
|
BLUE
83
DELISTED
bluebird bio
BLUE
| – | – |
-2,316
| Closed | -$1.85M |
|
84
Biogen
BIIB
$20.8B
| – | – |
-15,000
| Closed | -$4.25M |
|
|
AVDL
85
Avadel Pharmaceuticals
AVDL
$1.42B
| – | – |
-575,000
| Closed | -$5.97M |
|
86
Arcturus Therapeutics
ARCT
$467M
| – | – |
-71,429
| Closed | -$1.05M |
|
87
Aclaris Therapeutics
ACRS
$223M
| – | – |
-120,000
| Closed | -$3.26M |
|
|
88
Abbott
ABT
$230B
| – | – |
-400,000
| Closed | -$15.4M |
|
89
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|